Amylyx Pharmaceuticals Inc (AMLX)
1.64
-0.04
(-2.38%)
USD |
NASDAQ |
Jun 14, 16:00
1.64
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Cash and Short Term Investments (Quarterly): 373.29M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 373.29M |
| December 31, 2023 | 371.36M |
| September 30, 2023 | 355.04M |
| June 30, 2023 | 357.28M |
| March 31, 2023 | 345.67M |
| December 31, 2022 | 346.94M |
| Date | Value |
|---|---|
| September 30, 2022 | 162.59M |
| June 30, 2022 | 206.68M |
| March 31, 2022 | 255.20M |
| December 31, 2021 | 96.12M |
| September 30, 2021 | 125.70M |
| December 31, 2020 | 12.88M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
12.88M
Minimum
Dec 2020
373.29M
Maximum
Mar 2024
250.73M
Average
300.44M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| iRhythm Technologies Inc | 569.09M |
| Cassava Sciences Inc | 124.17M |
| Bristol-Myers Squibb Co | 9.67B |
| Moderna Inc | 8.523B |
| InfuSystems Holdings Inc | 0.822M |